Lung Cancer Immunotherapy Featured in CEOCFO Magazine

Batu Biologics’ Lung Cancer Immunotherapy Featured in CEOCFO Magazine
Anti-Angiogenesis Lung Cancer Vaccine Discussed as Potential “Next Generation” Non-Toxic Therapy

Given that the majority of lung cancers are diagnosed late in progression, the majority of patients have limited treatment options, which often carry a heavy burden of toxicity.

Read the full article at businesswire.com

0